Download presentation
Presentation is loading. Please wait.
Published byGinger Dickerson Modified over 9 years ago
1
TACTIC PROJECT 2: THE ROLE OF FACTOR XI IN TIC LEAD INVESTIGATOR: SAULIUS BUTENAS (UNIVERSITY OF VERMONT) CO-INVESTIGATOR: JAMES H MORRISSEY (UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN) PHILADELPHIA, SEPTEMBER 10, 2014 a
2
The Coagulation Cascade Intrinsic Pathway Factor XII Prekallikrein HMW Kininogen “Surface” Factor XIa HMW Kininogen Membrane Ca 2+, Zn 2+ Intrinsic Tenase AT-III IIa XIa Va i VIIIa i XIIa IXa Extrinsic Pathway Factor VIIa Tissue Factor Membrane Ca 2+ Factor IXa Factor VIIIa Membrane Ca 2+ Factor Xa Factor Va Membrane Ca 2+ Thrombin Thrombomodulin Membrane Ca 2+ Fibrin Clot Formation Extrinsic Tenase Prothrombinase Cross-Linked Fibrin Clot Soluble Fibrin Peptides TFPI AT-III PAI-1 AT-III TAFIa Plasmin APC 2 -AP AT-III XIIIa Fibrin IIa Xa IXa TFPI AT-III Red = Enzymes Yellow = Inhibitors Vascular Injury Tissue Factor IIa Va VIIIa
3
FXIa-Initiated Clotting of Whole Blood Initiator Concentration
4
Assays for FXIa Clotting and thrombin generation (TGA) assays were developed. Both assays are based on the response of contact pathway-inhibited (corn trypsin inhibitor; CTI) plasma to the inhibitory anti-FXI monoclonal antibody. No exogenous initiator of thrombin generation is added. No thrombin generation/clot formation is observed in plasma from healthy individuals
5
Study #1 (In collaboration with Dr. M. Park from Mayo Clinic) Multiple time-points from 98 patients: Burn 34 Blunt 47 Penetrating 17 Clotting assay was used for the quantitation of FXIa Supported by DoD and PO1 HL46703
10
*ISS – injury severity score. **Average ± SD for patients with FXIa ≥ 10 pM. Detectabiliy limit of FXIa in this clotting time-based assay is 10 pM. S. Butenas, M. Park, K. Mann (unpublished data). Active Factor XIa at Admission Injury ISS* > 25ISS ≤ 25 XIa Frequency(pM)**Frequency(pM) Burn13/19 (68%)38±363/15 (20%)47±7 Blunt19/31 (61%)39±287/16 (44%)37±26 Penetrating 3/7 (43%)55±651/10 (10%)160
11
Conclusion #1 The occurrence of FXIa correlates with the severity of trauma
13
Study #2 (In collaboration with Dr. J. Shupp from Washington Burn Center) 56 Burn patients 463 time-points Up to 20 time-points per patient from 0 to 504 hours (3 weeks) Thrombin Generation assay was used for the quantitation of FXIa Supported by Systems Biology grant
18
Conclusion #2 Of 56 burn patients analyzed: 62% had TF and 100% had FXIa at at least one time-point. TF activity was observed in 21% and FXIa in 90% time-point samples.
19
Study #3 (In collaboration with Dr. K. Freeman from FAHC, Burlington VT) Multiple time-point plasma samples from 66 patients (no burn patients; 187 time-points) 56% of them had TF and 94% had FXIa at at least one time-point. TF activity was observed in 30% and FXIa in 79% time-point samples. Thrombin Generation assay was used for the quantitation of FXIa Supported by Systems Biology grant
20
Final Conclusions The majority of trauma patients have circulating FXIa, which correlates with trauma severity. FXIa concentration over observation time varies in a wide range. The frequency of FXIa in burn patients is higher than in other trauma patient categories FXIa could be a potential marker of trauma severity
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.